{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:21:35Z","timestamp":1783657295408,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.conb.2020.01.011","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T17:04:50Z","timestamp":1582563890000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pathogenic A\u03b2 generation in familial Alzheimer\u2019s disease: novel mechanistic insights and therapeutic implications"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-1180","authenticated-orcid":false,"given":"Johannes","family":"Trambauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Fukumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2020.01.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004457","article-title":"Alzheimer\u2019s disease","volume":"3","author":"Selkoe","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.conb.2020.01.011_bib0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.15698\/cst2018.11.162","article-title":"Making the final cut: pathogenic amyloid \u03b2-peptide generation by \u03b3-secretase","volume":"2","author":"Steiner","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.conb.2020.01.011_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt107","article-title":"Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer\u2019s disease","volume":"4","author":"Weggen","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.conb.2020.01.011_bib0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","article-title":"Potent amyloidogenicity and pathogenicity of A\u03b243","volume":"14","author":"Saito","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2016.03.010","article-title":"Familial Alzheimer's disease mutations in presenilin generate amyloidogenic A\u03b2 peptide seeds","volume":"90","author":"Veugelen","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2020.01.011_bib0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15252\/emmm.201505952","article-title":"Generation and deposition of A\u03b243 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease","volume":"8","author":"Kretner","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0045","article-title":"Familial Alzheimer\u2019s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta","author":"Arber","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.conb.2020.01.011_bib0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.conb.2020.01.011_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2016.05.020","article-title":"Restricted location of PSEN2\/\u03b3-secretase determines substrate specificity and generates an intracellular A\u03b2 pool","volume":"166","author":"Sannerud","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.conb.2020.01.011_bib0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","article-title":"Longer forms of amyloid \u03b2 protein: implications for the mechanism of intramembrane cleavage by \u03b3-secretase","volume":"25","author":"Qi-Takahara","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0065","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"\u03b3-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of \u03b2-carboxyl terminal fragment","volume":"29","author":"Takami","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.celrep.2012.11.028","article-title":"\u03b3-Secretase modulators and presenilin 1 mutants act differently on presenilin\/\u03b3-secretase function to cleave A\u03b242 and A\u03b243","volume":"3","author":"Okochi","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2020.01.011_bib0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphys.2014.00463","article-title":"Molecular mechanism of the intramembrane cleavage of the \u03b2-carboxyl terminal fragment of amyloid precursor protein by \u03b3-secretase","volume":"5","author":"Morishima-Kawashima","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.conb.2020.01.011_bib0080","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Chavez-Gutierrez","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.conb.2020.01.011_bib0085","doi-asserted-by":"crossref","first-page":"31043","DOI":"10.1074\/jbc.M114.581165","article-title":"Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid \u03b2-peptides (A\u03b2) by \u03b3-secretase to increase 42-to-40-residue A\u03b2","volume":"289","author":"Fernandez","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0090","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","article-title":"Qualitative changes in human \u03b3-secretase underlie familial Alzheimer's disease","volume":"212","author":"Szaruga","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.conb.2020.01.011_sbref0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cell.2017.07.004","article-title":"Alzheimer's-causing mutations shift A\u03b2 length by destabilizing \u03b3-secretase-A\u03b2n Interactions","volume":"170","author":"Szaruga","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.conb.2020.01.011_bib0100","doi-asserted-by":"crossref","first-page":"24294","DOI":"10.1074\/jbc.M211161200","article-title":"Potential link between amyloid \u03b2-protein 42 and C-terminal fragment \u03b3 49-99 of \u03b2-amyloid precursor protein","volume":"278","author":"Sato","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0105","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.15252\/embj.201694151","article-title":"Substrate recruitment of \u03b3-secretase and mechanism of clinical presenilin mutations revealed by photoaffinity mapping","volume":"35","author":"Fukumori","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.conb.2020.01.011_sbref0110","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947996","article-title":"A\u03b243-producing PS1 FAD mutants cause altered substrate interactions and respond to \u03b3-secretase modulation","volume":"21","author":"Trambauer","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.conb.2020.01.011_bib0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17578","article-title":"The amyloid-\u03b2 forming tripeptide cleavage mechanism of \u03b3-secretase","volume":"5","author":"Bolduc","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.conb.2020.01.011_sbref0120","doi-asserted-by":"crossref","first-page":"eaaw0930","DOI":"10.1126\/science.aaw0930","article-title":"Recognition of the amyloid precursor protein by human \u03b3-secretase","volume":"363","author":"Zhou","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.conb.2020.01.011_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/156720512799361600","article-title":"An overview of notch signaling in adult tissue renewal and maintenance","volume":"9","author":"Sato","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.conb.2020.01.011_sbref0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0813-8","article-title":"Structural basis of Notch recognition by human \u03b3-secretase","volume":"565","author":"Yang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.conb.2020.01.011_bib0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-pharmtox-010814-124309","article-title":"Learning by failing: ideas and concepts to tackle \u03b3-secretases in Alzheimer's disease and beyond","volume":"55","author":"De Strooper","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.conb.2020.01.011_bib0140","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1021\/acs.jmedchem.5b01960","article-title":"\u03b3-Secretase modulators: new Alzheimer\u2019s drugs on the horizon?","volume":"59","author":"Bursavich","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.M708754200","article-title":"Generation of A\u03b238 and A\u03b242 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and \u03b3-secretase modulation","volume":"283","author":"Page","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.conb.2020.01.011_bib0155","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neuron.2010.08.018","article-title":"Modulation of \u03b3-secretase reduces \u03b2-amyloid deposition in a transgenic mouse model of Alzheimer's disease","volume":"67","author":"Kounnas","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2020.01.011_bib0160","doi-asserted-by":"crossref","first-page":"17798","DOI":"10.1074\/jbc.M110.103283","article-title":"\u03b2-Amyloid precursor protein mutants respond to \u03b3-secretase modulators","volume":"285","author":"Page","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-4159.2010.07118.x","article-title":"Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to \u03b3-secretase modulators regardless of their potency and structure","volume":"116","author":"Hahn","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2020.01.011_bib0170","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M110.213587","article-title":"Attenuated A\u03b242 responses to low potency \u03b3-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds","volume":"286","author":"Kretner","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0175","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.112686799","article-title":"Presenilin-1 mutations of leucine 166 equally affect the generation of the notch and APP intracellular domains independent of their effect on A\u03b242 production","volume":"99","author":"Moehlmann","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2020.01.011_bib0180","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jamaneurol.2014.2482","article-title":"Effect of potent \u03b3-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers","volume":"71","author":"Liu","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.01.011_bib0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","article-title":"A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP \u03b2-CTFs, not A\u03b2","volume":"104","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2020.01.011_sbref0190","doi-asserted-by":"crossref","first-page":"103392","DOI":"10.1016\/j.mcn.2019.103392","article-title":"\u03b3-Secretase modulators and BACE inhibitors reduce A\u03b2 production without altering gene expression in Alzheimer's disease iPSC-derived neurons and mice","volume":"100","author":"Cusulin","year":"2019","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0195","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.celrep.2017.10.109","article-title":"iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid \u03b2 combination for Alzheimer's disease","volume":"21","author":"Kondo","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2020.01.011_bib0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.celrep.2015.03.068","article-title":"APP metabolism regulates tau proteostasis in human cerebral cortex neurons","volume":"11","author":"Moore","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2020.01.011_bib0205","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ajpath.2012.02.012","article-title":"Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of \u03b3-secretase activity in endogenous amyloid-\u03b2 generation","volume":"180","author":"Koch","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.conb.2020.01.011_bib0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer\u2019s disease with iPSC-derived brain cells","volume":"25","author":"Penney","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.conb.2020.01.011_bib0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-2010-1366","article-title":"CHF5074, a novel \u03b3-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease","volume":"20","author":"Imbimbo","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.conb.2020.01.011_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1750-1326-7-61","article-title":"Modulation of \u03b3-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice","volume":"7","author":"Rogers","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.conb.2020.01.011_bib0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-14-44","article-title":"Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice","volume":"14","author":"Sivilia","year":"2013","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0230","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/mp.2015.74","article-title":"Amyloid-PET predicts inhibition of de novo plaque formation upon chronic \u03b3-secretase modulator treatment","volume":"20","author":"Brendel","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.conb.2020.01.011_bib0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ebiom.2017.08.028","article-title":"Soluble \u03b3-secretase modulators attenuate Alzheimer's \u03b2-amyloid pathology and induce conformational changes in presenilin 1","volume":"24","author":"Raven","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.conb.2020.01.011_bib0240","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","article-title":"Differential effects between \u03b3-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice","volume":"32","author":"Mitani","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.117.240861","article-title":"Pharmacological and toxicological properties of the potent oral \u03b3-secretase modulator BPN-15606","volume":"362","author":"Wagner","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.conb.2020.01.011_bib0250","doi-asserted-by":"crossref","first-page":"37181","DOI":"10.1074\/jbc.C111.276972","article-title":"Novel \u03b3-secretase enzyme modulators directly target presenilin protein","volume":"286","author":"Ebke","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_bib0255","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1038\/emboj.2011.372","article-title":"Phenylpiperidine-type \u03b3-secretase modulators target the transmembrane domain 1 of presenilin 1","volume":"30","author":"Ohki","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.conb.2020.01.011_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030484","article-title":"Presenilin is the molecular target of acidic \u03b3-secretase modulators in living cells","volume":"7","author":"Jumpertz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.conb.2020.01.011_bib0265","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1074\/jbc.M112.398602","article-title":"\u03b3-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin","volume":"288","author":"Pozdnyakov","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2020.01.011_sbref0270","doi-asserted-by":"crossref","first-page":"12272","DOI":"10.1523\/JNEUROSCI.1628-17.2017","article-title":"Activation of \u03b3-secretase trimming activity by topological changes of transmembrane domain 1 of presenilin 1","volume":"37","author":"Cai","year":"2017","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0275","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cn200098p","article-title":"Piperidine acetic acid based \u03b3-secretase modulators directly bind to Presenilin-1","volume":"2","author":"Crump","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_bib0280","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.1402171111","article-title":"Allosteric regulation of \u03b3-secretase activity by a phenylimidazole-type \u03b3-secretase modulator","volume":"111","author":"Takeo","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2020.01.011_sbref0285","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101494","article-title":"Extracellular interface between APP and Nicastrin regulates A\u03b2 length and response to \u03b3-secretase modulators","volume":"38","author":"Petit","year":"2019","journal-title":"EMBO J"},{"key":"10.1016\/j.conb.2020.01.011_bib0290","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/jnc.12129","article-title":"Substrate determinants in the C99 juxtamembrane domains differentially affect \u03b3-secretase cleavage specificity and modulator pharmacology","volume":"125","author":"Ousson","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2020.01.011_bib0295","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/bi401521t","article-title":"Complex relationships between substrate sequence and sensitivity to alterations in \u03b3-secretase processivity induced by \u03b3-secretase modulators","volume":"53","author":"Jung","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.conb.2020.01.011_bib0300","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1112","article-title":"Nonsteroidal anti-inflammatory drugs lower A\u03b242 and change presenilin 1 conformation","volume":"10","author":"Lleo","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007893","article-title":"Allosteric modulation of PS1\/\u03b3-secretase conformation correlates with amyloid \u03b2(42\/40) ratio","volume":"4","author":"Uemura","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.conb.2020.01.011_bib0310","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-150313","article-title":"\u03b3-Secretase modulators and inhibitors induce different conformational changes of presenilin 1 revealed by FLIM and FRET","volume":"47","author":"Wang","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.conb.2020.01.011_bib0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.116.232249","article-title":"Robust translation of \u03b3-secretase modulator pharmacology across preclinical species and human subjects","volume":"358","author":"Toyn","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.conb.2020.01.011_bib0320","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcph.249","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel \u03b3-secretase modulator, E2212, in healthy human subjects","volume":"54","author":"Yu","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.conb.2020.01.011_bib0325","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.116.232256","article-title":"The \u03b3-secretase modulator, BMS-932481, modulates A\u03b2 peptides in the plasma and cerebrospinal fluid of healthy volunteers","volume":"358","author":"Soares","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.conb.2020.01.011_sbref0330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cpt.1570","article-title":"Pharmacokinetic and pharmacodynamic effects of a \u03b3-secretase modulator, PF-06648671, on CSF amyloid-\u03b2 peptides in randomized Phase 1 studies","volume":"107","author":"Ahn","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.conb.2020.01.011_bib0335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.conb.2020.01.011_bib0340","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease","volume":"378","author":"Egan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0350","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","article-title":"Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial","volume":"72","author":"Coric","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.01.011_bib0355","doi-asserted-by":"crossref","first-page":"16243","DOI":"10.1523\/JNEUROSCI.2775-12.2012","article-title":"The \u03b2-secretase-derived C-terminal fragment of \u03b2APP, C99, but not A\u03b2, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus","volume":"32","author":"Lauritzen","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2020.01.011_sbref0360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.celrep.2017.09.032","article-title":"Semagacestat is a pseudo-inhibitor of \u03b3-secretase","volume":"21","author":"Tagami","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2020.01.011_sbref0365","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20170600","article-title":"Short A\u03b2 peptides attenuate A\u03b242 toxicity in vivo","volume":"215","author":"Moore","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.conb.2020.01.011_bib0370","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2020.01.011_bib0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/alzrt213","article-title":"Dominantly inherited Alzheimer network: facilitating research and clinical trials","volume":"5","author":"Moulder","year":"2013","journal-title":"Alzheimers Res Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.conb.2020.01.011_bib0380","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.conb.2020.01.011_bib0385","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.1997.03540340027028","article-title":"Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation","volume":"277","author":"Lopera","year":"1997","journal-title":"JAMA"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438820300313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438820300313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:54:33Z","timestamp":1760705673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438820300313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":77,"alternative-id":["S0959438820300313"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2020.01.011","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic A\u03b2 generation in familial Alzheimer\u2019s disease: novel mechanistic insights and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2020.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}